Hospitalized patients with acute medical illnesses are at significant risk for venous thromboembolism (VTE) during and after a hospital stay. Strategies for optimal pharmacologic VTE thromboprophylaxis are evolving but necessary to protect high-risk patients after hospital discharge.

NATF is proud to launch the Anticoagulation Action Initiative to help drive the appropriate use of VTE prophylaxis in medically ill patients. Developed by a panel of global experts, this consensus document explores the most recent data on extended-duration prophylaxis and serves as a practical, contemporary guide for frontline providers and stakeholders, including hospitalists, internal medicine practitioners, pharmacists, nurse practitioners, physician assistants, subspecialty clinicians, and hematology, pulmonary medicine, and cardiovascular medicine staff.


NATF Action Initiative Consensus Group Members

Ebrahim Barkoudah, MD, MPH (Chair)
Harvard Medical School
Brigham and Women’s Hospital

Geoffrey D. Barnes, MD, MSc
University of Michigan Medical School

Thomas Chen, MD, PharmD
University of Chicago Medicine

Jean M. Connors, MD
Harvard Medical School
Brigham and Women’s Hospital

Steven Deitelzweig, MD
Ochsner Clinic Foundation, Ochsner Health System

Margaret C. Fang, MD, MPH
University of California

John Fanikos, RPh, MBA
Massachusetts College of Pharmacy and Health Science
Brigham and Women’s Hospital

Samuel Z. Goldhaber, MD
Harvard Medical School
Brigham and Women’s Hospital

Jennifer N. Goldstein, MD, MSc
Christiana Care Health System

Paul Grant, MD
University of Michigan Medical School

Todd E.H. Hecht, MD
Perelman School of Medicine, University of Pennsylvania

Scott Kaatz, DO, MSc
Henry Ford Hospital
Wayne State University

Cheng-Kai Kao, MD
University of Chicago Medicine

Gregory Piazza, MD, MS
Harvard Medical School
Brigham and Women’s Hospital

Tea Ramishvili, MD
Christiana Care Health System

Christian T. Ruff, MD, MPH
Harvard Medical School
Brigham and Women’s Hospital

Jeffrey L. Schnipper, MD, MPH
Harvard Medical School
Brigham and Women’s Hospital

Aviva Schwartz, MA
North American Thrombosis Forum

A special thank you to the Initiative’s corporate sponsor: